Phenotypically, NLCs are considered as CLL-specific M2-skewed tumor associated macrophages characterized by high CD11b, CD163, CD206, HLA-DR, HGF and IDO expression [8–12] and by dysregulation of genes involved in immunocompetence [13]. Here, MRC1 is linked to B-cell chronic lymphocytic leukemia.